Use of lytic toxins and toxin conjugates
View Patent ↗Agents are provided which are capable of inhibiting the cell division cycle in a target cell of interest. The agents comprise first and second components, wherein the first component is a targeting moiety which is capable of directing the second component to the target cell of interest. The second component is capable of inhibiting the cell division cycle in the target cell of interest. The agents are preferably provided in the form of conjugates, and the second component is preferably a cytolethal distending toxin. Methods for the preparation of the agents, and the use thereof for treating proliferative cell disorders and intracellular pathogens are also provided.
1. An isolated nucleic acid sequence comprising the sequence of SEQ ID NO: 1 and/or SEQ ID NO: 3.
2. An isolated peptide sequence comprising the sequence SEQ ID 2 and/or SEQ ID 4.
3. An agent comprising first and second components, the first component being a targeting moiety (TM) and the second component being a DNase that is a cytolethal distending toxin (CDT), wherein the TM is capable of directing the second component to the target cell of interest, and wherein the DNase causes death to the target cell by a lytic mechanism, wherein the second component comprises SEQ ID 2 and/or SEQ ID 4.
4. A method for preparing an agent according to claim 3 comprising expression of one or more nucleic acid constructs encoding the first and second components, wherein the nucleic acid construct encoding the second component comprises SEQ ID 1 and/or SEQ ID 3.